Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Felix

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|August 11, 1992
Absence of hereditary p53 mutations in 10 familial leukemia pedigreesC A Felix, D D'Amico, T Mitsudomi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocationB D Lovett, L Lo Nigro, E F Rappaport, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Molecular pathogenesis of secondary acute promyelocytic leukemiaM Joannides, A N Mays, A R Mistry, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromesM D Megonigal, E F Rappaport, D H Jones, et al.
Biochemistry|February 15, 2001
Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpointsB D Lovett, D Strumberg, I A Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Association of CYP3A4 genotype with treatment-related leukemiaC A Felix, A H Walker, B J Lange, et al.
Lancet (London, England)|July 16, 1999
High incidence of secondary brain tumours after radiotherapy and antimetabolitesM V Relling, J E Rubnitz, G K Rivera, et al.
Blood|January 7, 1998
Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner geneC A Felix, C S Kim, M D Megonigal, et al.
Blood|May 15, 1996
The p53 gene in pediatric therapy-related leukemia and myelodysplasiaC A Felix, M R Hosler, D Provisor, et al.
Blood|June 17, 1998
Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemiaC A Felix, M D Megonigal, D S Chervinsky, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|August 11, 1992
Absence of hereditary p53 mutations in 10 familial leukemia pedigreesC A Felix, D D'Amico, T Mitsudomi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocationB D Lovett, L Lo Nigro, E F Rappaport, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Molecular pathogenesis of secondary acute promyelocytic leukemiaM Joannides, A N Mays, A R Mistry, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromesM D Megonigal, E F Rappaport, D H Jones, et al.
Biochemistry|February 15, 2001
Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpointsB D Lovett, D Strumberg, I A Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Association of CYP3A4 genotype with treatment-related leukemiaC A Felix, A H Walker, B J Lange, et al.
Lancet (London, England)|July 16, 1999
High incidence of secondary brain tumours after radiotherapy and antimetabolitesM V Relling, J E Rubnitz, G K Rivera, et al.
Blood|January 7, 1998
Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner geneC A Felix, C S Kim, M D Megonigal, et al.
Blood|May 15, 1996
The p53 gene in pediatric therapy-related leukemia and myelodysplasiaC A Felix, M R Hosler, D Provisor, et al.
Blood|June 17, 1998
Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemiaC A Felix, M D Megonigal, D S Chervinsky, et al.
Pageof 6